BridgeBio Oncology Therapeutics, Inc. (NASDAQ:BBOT) IPO

BridgeBio Oncology Therapeutics, Inc.

IPO

Went public as Helix Acquisition Corp. II, a blank check company (SPAC). Priced at US$10.00 a share on Feb 8, 2024.

Price
US$10.00 a share
Shares offered
16,000,000 Class A ordinary shares
Offering size
US$160 million
Underwriters' option
Up to 2,400,000 more shares
Listing
HLXB on the Nasdaq Global Market
Underwriter
Leerink Partners
Shares delivered
On or about Feb 13, 2024

Steps

StepWhen
Draft sent to the SEC in confidenceDec 20, 2023
Filed publiclyJan 18, 2024
Amended twiceNewest Feb 7, 2024
Shares registered with an exchangeFeb 8, 2024
Declared effective by the SECFeb 8, 2024
Final prospectus, with the priceFeb 13, 2024

From the cover of the final prospectus (424B4) filed Feb 13, 2024